COVID-19 vaccine-associated lymphadenopathy (C19-VAL) is increasingly encountered
with the widespread use of the vaccine in controlling the outbreak. We aim to characterize …

Abstract Purpose Lymphadenopathy (LAP) after COVID-19 vaccination in patients with a
diagnosis of cancer has been challenging. We analyzed imaging and clinical features from …

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram |
Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All …

B-cell lymphomas are neoplastic diseases occasionally associated with chronic
inflammation. mRNA vaccines for coronavirus disease 2019 (COVID-19) induce …

Background Both temporal changes in imaging characteristics of lymphadenopathy on US
scans after COVID-19 vaccination and expected duration of radiologically evident …

Axillary lymphadenopathy caused by the high immunogenicity of messenger RNA (mRNA)
COVID-19 vaccines presents radiologists with new diagnostic dilemmas in differentiating …

Background COVID-19 vaccination-related axillary lymphadenopathy has become an
important problem in cancer imaging. Data are needed to update or support imaging …

Please see the Editorial Comment by Hannah Perry discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes, Google Play …

Background: The recent COVID-19 pandemic produced a significant increase in cases and
an emergency state was induced worldwide. The current knowledge about the COVID-19 …

SBI Recommendations for Managing Axillary Adenopathy Post-COVID Vaccination (Updated
February 2022) Page 1 Updated February 2022 Revised SBI Recommendations for the …